Key Takeaways
- Rocket Lab finalized its at-the-market equity program, offloading approximately 6.7 million shares and generating around $474 million in gross capital.
- The aerospace firm simultaneously executed collared forward agreements covering roughly 7.5 million shares, projecting proceeds ranging from $474 million to $642 million.
- Capital raised will support expansion initiatives, possible mergers and acquisitions, and operational funding requirements.
- Citizens analyst Trevor Walsh elevated RKLB from Hold to Buy status while maintaining an $85 price objective.
- Wall Street’s consensus price target stands at $86.77, suggesting approximately 25.6% appreciation potential from present valuations.
Rocket Lab wrapped up its billion-dollar at-the-market equity program this Wednesday, securing approximately $474 million in gross capital. Shares responded with a roughly 5% advance following the announcement.
The aerospace company divested close to 6.7 million shares via at-the-market mechanisms. Simultaneously, the firm structured collared forward agreements encompassing approximately 7.5 million shares.
These forward contracts establish a floor of about $474 million in anticipated proceeds, with a ceiling near $642 million. Settlement is scheduled for April 2028, although the company retains the flexibility to settle earlier if advantageous.
The equity program originated on March 17, 2026, when Rocket Lab submitted a prospectus supplement authorizing up to $1 billion in share sales. Wednesday’s announcement marks the program’s official conclusion.
Rocket Lab disclosed that net proceeds will finance expansion efforts, including prospective acquisitions, alongside general corporate operations and working capital needs. The company has not identified specific acquisition candidates.
The share price appreciation coincided with a generally favorable trading environment across equity markets, providing supportive momentum.
Wall Street Upgrades Drive Positive Sentiment
Earlier in the week, Trevor Walsh of Citizens elevated his rating on RKLB from Hold to Buy. His $85 price objective remained unchanged, representing approximately 25% upside potential from recent trading levels.
Walsh emphasized current valuations as an attractive entry opportunity. He also highlighted Rocket Lab’s strategic pivot toward defense contracts and space services as pathways to improved profit margins and revenue consistency.
Walsh referenced the forthcoming SpaceX public offering — with potential valuation reaching $2 trillion — as a possible catalyst to drive increased investor focus toward the commercial space industry.
Sujeeva De Silva of Roth MKM maintained his Buy recommendation alongside a $90 price objective. De Silva emphasized the company’s expanding order book and its strategic shift into satellite component manufacturing.
De Silva characterized Rocket Lab as “successfully diversifying into Space Systems,” transitioning beyond pure launch services. He interprets the growing backlog as confirmation of substantial growth runway.
According to TipRanks data, RKLB carries a Moderate Buy consensus among analysts. The rating reflects 10 Buy recommendations and five Hold ratings issued over the past three months.
The consensus price objective across these analysts reaches $86.77, implying roughly 25.6% appreciation potential from current market prices.
Neutron Vehicle Development Remains Critical Focus
Beyond the capital raise, Rocket Lab’s Neutron launch system continues drawing significant industry attention. The 43-meter partially reusable rocket targets satellite deployment and cargo transportation missions.
Critical systems — including the “Hungry Hippo” payload fairing and structural thrust components — have progressed to final integration stages. Initial launch operations are projected for late 2026 or early 2027.
Clear Street analyst Gregory Pendy observed that Neutron could access substantially larger market opportunities compared to Electron while delivering superior revenue economics per mission. This positions the vehicle as a crucial growth driver for the organization.
Rocket Lab’s equity has experienced considerable volatility throughout 2026, posting minimal net returns year-to-date. The Street’s average price target currently registers at $86.77.
